GR3004285T3 - - Google Patents

Info

Publication number
GR3004285T3
GR3004285T3 GR920400639T GR920400639T GR3004285T3 GR 3004285 T3 GR3004285 T3 GR 3004285T3 GR 920400639 T GR920400639 T GR 920400639T GR 920400639 T GR920400639 T GR 920400639T GR 3004285 T3 GR3004285 T3 GR 3004285T3
Authority
GR
Greece
Prior art keywords
mononitrate
tablets
time
isosorbide
stable
Prior art date
Application number
GR920400639T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3004285T3 publication Critical patent/GR3004285T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR920400639T 1985-10-15 1992-04-07 GR3004285T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22493/85A IT1187750B (it) 1985-10-15 1985-10-15 Procedimento per la preparazione di compresse,anche a rilascio prolungato,di iscsorbide-5-mononitrato stabilizzato e formulazioni cosi' ottenute

Publications (1)

Publication Number Publication Date
GR3004285T3 true GR3004285T3 (el) 1993-03-31

Family

ID=11197007

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400639T GR3004285T3 (el) 1985-10-15 1992-04-07

Country Status (12)

Country Link
US (1) US4812316A (el)
EP (1) EP0219161B1 (el)
JP (1) JPS62123114A (el)
AT (1) ATE71290T1 (el)
AU (1) AU591185B2 (el)
CA (1) CA1285489C (el)
DE (1) DE3683342D1 (el)
ES (1) ES2035819T3 (el)
GR (1) GR3004285T3 (el)
HK (1) HK12295A (el)
IT (1) IT1187750B (el)
ZA (1) ZA867768B (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64726B1 (en) * 1987-11-20 1995-08-23 Elan Corp Plc Pharmaceutical formulations for preventing drug tolerance
IT1237638B (it) * 1989-10-25 1993-06-12 Ghirardi Paolo E. Impiego dell'isosorbide 2-mononitrato per la preparazione di composi- zioni farmaceutiche atte al trattamento dell'angina pectoris
FR2666506A1 (fr) * 1990-09-07 1992-03-13 Pf Medicament Comprime a liberation prolongee a base de 5-mononitrate d'isosorbide et son procede de preparation.
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE4313726A1 (de) * 1993-04-27 1994-11-03 Byk Nederland Bv Feste Darreichungsform
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
DE19515972A1 (de) * 1995-05-02 1996-11-07 Bayer Ag Arzneizubereitungen mit kontrollierter Freisetzung und Verfahren zu ihrer Herstellung
US5900425A (en) * 1995-05-02 1999-05-04 Bayer Aktiengesellschaft Pharmaceutical preparations having controlled release of active compound and processes for their preparation
AU3861397A (en) * 1996-08-02 1998-02-25 Cal International Limited Controlled release tablet formulation of isosorbide-5-mononitrate
US5851555A (en) * 1997-08-15 1998-12-22 Fuisz Technologies Ltd. Controlled release dosage forms containing water soluble drugs
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
US6410520B2 (en) 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
JP4696210B2 (ja) * 2000-06-07 2011-06-08 トーアエイヨー株式会社 イソソルビド‐５‐モノニトレートを有効成分とする徐放性錠剤及びその製造方法
JP4840549B2 (ja) * 2000-11-20 2011-12-21 トーアエイヨー株式会社 安定な血管拡張剤及びその製造方法
US7008979B2 (en) * 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
EP2004138B1 (en) * 2006-03-16 2013-11-20 Glycologic Limited Gastric raft composition comprising processed starches for inducing satiety
CN111068644B (zh) * 2019-12-20 2023-01-03 中海油天津化工研究设计院有限公司 一种均四甲苯氧化制均酐催化剂及其制备方法
CN115487162B (zh) * 2022-10-13 2023-10-13 山东力诺制药有限公司 一种单硝酸异山梨酯缓释片的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2301664C3 (de) * 1973-01-13 1979-07-12 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral verabreichbares, Nitroglycerin enthaltendes Arzneimittel
US3972995A (en) * 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3325652A1 (de) * 1983-07-15 1985-01-24 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Feste, stabile isosorbid-5-mononitrat enthaltende arzneimittelzubereitungen und verfahren zu ihrer herstellung
JPS60181052A (ja) * 1984-02-29 1985-09-14 Tooa Eiyoo Kk 安定なイソソルビド硝酸エステル組成物及びその製造法

Also Published As

Publication number Publication date
ES2035819T3 (es) 1993-05-01
IT1187750B (it) 1987-12-23
HK12295A (en) 1995-02-03
IT8522493A0 (it) 1985-10-15
EP0219161A3 (en) 1988-01-13
JPS62123114A (ja) 1987-06-04
ATE71290T1 (de) 1992-01-15
CA1285489C (en) 1991-07-02
DE3683342D1 (de) 1992-02-20
EP0219161A2 (en) 1987-04-22
AU6383186A (en) 1987-04-16
EP0219161B1 (en) 1992-01-08
US4812316A (en) 1989-03-14
JPH0524888B2 (el) 1993-04-09
AU591185B2 (en) 1989-11-30
ZA867768B (en) 1987-06-24

Similar Documents

Publication Publication Date Title
GR3004285T3 (el)
YU82875A (en) Preparation of substituted 2,6-dimethylanilides of 2-carboxylic acid with fungicidal activity
NO880950L (no) Fremstilling av oksygen med hoey renhet.
ZA763627B (en) Preparation of aqueous soy protein
ZA864872B (en) Isoxazole and furan derivatives,their preparation and use as antiviral agents
AU513890B2 (en) Water-insoluble biologically active compounds
IL53535A (en) Stabilized folic acid, its preparation and animal feed materals comprising it
ES448588A1 (es) Un procedimiento para la preparacion de un compuesto hetero-arilico.
DE2860270D1 (en) Novel derivatives of substituted 2-benzoyl-4-chloro-glycinanilides, their preparation and their use as medicines.
ZA787399B (en) Medicine with activity as prostaglandin synthetase inhibitor
GB1548676A (en) Preparation of 4,4,6-trimethyl-2-cyclohexenone
ES452943A1 (es) Procedimiento para preparar 1,2,3,4-tetrahidro-4-oxo-1-naf- tilisocianato e isotiocianato.
GB1537891A (en) Preparation of 2-formyl-quinoxaline-1,4-dioxide derivatives
JPS53149940A (en) Novel benzyl alcohol derivatives and their preparation
DE3660806D1 (en) Novel compound, its production and insecticidal and acaricidal composition containing it as an active ingredient
JPS51147144A (en) Information processor
JPS5430185A (en) Mandelic acid derivative and carcinostatic agnet containing the same
ZA867343B (en) Use of thienylamines as production-promoting agents,new thienylamine
IL53550A0 (en) The preparation of o,o-dialkyl-s-(n-methyl-carboxamidomethyl)-thiol-phosphoric acid esters
JPS5210881A (en) Fluorescent substances
GR61733B (en) Preparation of dialkalimetal hexahydropyrimidine-1,3-diacetate and dialkalimetal 5-hydroxyhexahydropyrimidine-1,3-diacetate
JPS527634A (en) Light pen
JPS5281475A (en) Disc brake
JPS5288205A (en) Pressing-in accompanying sintered metal parts
吴江 Psycholinguistics: An Introduction to the Psychology of Language